These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7540143)

  • 1. Structural requirements for neuropeptide Y in mast cell and G protein activation.
    Mousli M; Trifilieff A; Pelton JT; Gies JP; Landry Y
    Eur J Pharmacol; 1995 Mar; 289(1):125-33. PubMed ID: 7540143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of positive charges of neuropeptide Y fragments in mast cell activation.
    Mousli M; Landry Y
    Agents Actions; 1994 Jun; 41 Spec No():C41-2. PubMed ID: 7526655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins?
    Grundemar L; Krstenansky JL; Håkanson R
    Eur J Pharmacol; 1994 Jun; 258(1-2):163-6. PubMed ID: 7523149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.
    Emadi-Khiav B; Mousli M; Bronner C; Landry Y
    Eur J Pharmacol; 1995 Jan; 272(1):97-102. PubMed ID: 7536161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.
    Cross LJ; Beck-Sickinger AG; Bienert M; Gaida W; Jung G; Krause E; Ennis M
    Br J Pharmacol; 1996 Jan; 117(2):325-32. PubMed ID: 8789386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
    Grundemar L; Håkanson R
    Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents.
    Shen GH; Grundemar L; Zukowska-Grojec Z; Håkanson R; Wahlestedt C
    Eur J Pharmacol; 1991 Nov; 204(3):249-56. PubMed ID: 1723049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y-induced mast cell activation.
    Cross LJ; Beck-Sickinger AG; Beyerman M; Krause E; Bienert M; Ennis M
    Biochem Soc Trans; 1994 Feb; 22(1):7S. PubMed ID: 7515834
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of alpha-helicity, amphipathicity and D-amino acid incorporation on the peptide-induced mast cell activation.
    Cross LJ; Ennis M; Krause E; Dathe M; Lorenz D; Krause G; Beyermann M; Bienert M
    Eur J Pharmacol; 1995 Nov; 291(3):291-300. PubMed ID: 8719413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
    Mousli M; Hugli TE; Landry Y; Bronner C
    J Immunol; 1992 Apr; 148(8):2456-61. PubMed ID: 1373170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells.
    Emadi-Khiav B; Mousli M; Landry Y
    Inflamm Res; 1995 Apr; 44 Suppl 1():S26-7. PubMed ID: 8520984
    [No Abstract]   [Full Text] [Related]  

  • 12. A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin.
    Bueb JL; Mousli M; Landry Y; Bronner C
    Agents Actions; 1990 Apr; 30(1-2):98-101. PubMed ID: 1695472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of exocytosis by the heterotrimeric G protein Gi3.
    Aridor M; Rajmilevich G; Beaven MA; Sagi-Eisenberg R
    Science; 1993 Dec; 262(5139):1569-72. PubMed ID: 7504324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The M2 muscarinic receptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins.
    Chahdi A; Daeffler L; Bueb JL; Gies JP; Landry Y
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):357-62. PubMed ID: 9606019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidergic pathway in human skin and rat peritoneal mast cell activation.
    Mousli M; Hugli TE; Landry Y; Bronner C
    Immunopharmacology; 1994; 27(1):1-11. PubMed ID: 7515863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midkine induces histamine release from mast cells and the immediate cutaneous response.
    Hiramatsu K; Yoshida H; Kimura T; Takagi K
    Biochem Mol Biol Int; 1998 Mar; 44(3):453-62. PubMed ID: 9556205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
    Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y
    Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenomedullin and proadrenomedullin N-terminal 20 peptide induce histamine release from rat peritoneal mast cell.
    Yoshida M; Yoshida H; Kitaichi K; Hiramatsu K; Kimura T; Ito Y; Kume H; Yamaki K; Suzuki R; Shibata E; Hasegawa T; Takagi K
    Regul Pept; 2001 Sep; 101(1-3):163-8. PubMed ID: 11495692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface.
    Chahdi A; Mousli M; Landry Y
    Eur J Pharmacol; 1998 Jan; 341(2-3):329-35. PubMed ID: 9543256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of basic secretagogue-induced signaling in mast cells by cell permeable G alpha i-derived peptides.
    Shefler I; Zavaro O; Raz T; Baram D; Sagi-Eisenberg R
    Int Arch Allergy Immunol; 2008; 145(2):131-40. PubMed ID: 17848806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.